Revolution Medicines exec sells 132,871 shares

Revolution Medicines insider Mark A. Goldsmith reported sales of Common Stock via Form 144.

Rhea-AI Filing Summary

Revolution Medicines insider Mark A. Goldsmith reported sales of Common Stock via Form 144. The filing lists a transfer of 12,871 shares on 03/17/2026 for $1,280,412.23 and a transfer of 120,000 shares on 04/15/2026 for $18,010,488.00. The filing also shows restricted stock unit grants of 3,488, 3,018 and 3,266 awarded on 03/01/2023, 03/01/2024 and 03/01/2025, respectively.

Insights

Securities Compliance Counsel

Form 144 lists reported dispositions by Mark A. Goldsmith totaling 132,871 shares across two transactions.

Form 144 is the notice required when an affiliate intends to sell restricted or control securities in reliance on Rule 144. The filing here records two reported transfers dated 03/17/2026 and 04/15/2026 with corresponding share counts and dollar amounts.

These entries should be read as reported dispositions; timing, method of sale, and whether sales were pursuant to pre-existing plans are not specified in the excerpt. Subsequent public filings may provide additional context about sale mechanics or tax-related withholding.

Key Figures

Sale on 03/17/2026: 12,871 shares Proceeds on 03/17/2026: $1,280,412.23 Sale on 04/15/2026: 120,000 shares +4 more

7 metrics

Sale on 03/17/2026 12,871 shares reported transfer dated 03/17/2026

Proceeds on 03/17/2026 $1,280,412.23 aggregate dollar amount shown with 03/17/2026 transfer

Sale on 04/15/2026 120,000 shares reported transfer dated 04/15/2026

Proceeds on 04/15/2026 $18,010,488.00 aggregate dollar amount shown with 04/15/2026 transfer

RSU grant 03/01/2023 3,488 shares Restricted stock unit grant dated 03/01/2023

RSU grant 03/01/2024 3,018 shares Restricted stock unit grant dated 03/01/2024

RSU grant 03/01/2025 3,266 shares Restricted stock unit grant dated 03/01/2025

Key Terms

Form 144, Restricted stock unit grant, Securities To Be Sold

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted stock unit grant financial

"Common Stock | 03/01/2023 | Restricted stock unit grant"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Mark A. Goldsmith report on Form 144 for RVMD?

He reported dispositions of 12,871 shares on 03/17/2026 for $1,280,412.23 and 120,000 shares on 04/15/2026 for $18,010,488.00. The filing lists those sale amounts and dates.

Does the filing show restricted awards for Revolution Medicines (RVMD)?

Yes. It lists Restricted Stock Unit grants of 3,488 awarded 03/01/2023, 3,018 awarded 03/01/2024, and 3,266 awarded 03/01/2025. These are shown with their grant dates.

Do the Form 144 entries state how the shares were sold?

The excerpt records share counts, dates, and aggregate dollar amounts but does not describe the sale method. The filing does not specify whether sales were open-market, block trades, or under a plan in the provided text.

What dollar amounts are reported for the April 2026 transaction?

The April 04/15/2026 entry reports a transfer of 120,000 shares for $18,010,488.00. That dollar figure appears alongside the share count in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 06:30 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001246842
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	4157663638
Name of Person for Whose Account the Securities are To Be Sold	GOLDSMITH MARK A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	9772	1503617.64	212596462	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			3488	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			3018	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			3266	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark A. Goldsmith c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/17/2026	12871	1280412.23
Mark A. Goldsmith c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	04/15/2026	120000	18010488.00

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/31/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-fact for Mark A. Goldsmith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)